# LPL Financial Holdings Inc.: overview

LPLA · Nasdaq · CIK 1397911 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lpla.md) · [Financials](/companies/lpla/financials.md) · [Filings](/companies/lpla/filings.md) · [Insiders](/companies/lpla/insiders.md)

Latest reported revenue: [$5.34bn](/filings/0001628280-26-068226.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-068226).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,512 d](/filings/0001628280-26-010705.md) | [3,670](/filings/0001628280-26-029530.md) | [3,835](/filings/0001628280-26-051542.md) | [4,552](/filings/0001628280-26-068226.md) | [4,932 d](/filings/0001628280-26-010705.md) | [4,938](/filings/0001628280-26-029530.md) | [5,187](/filings/0001628280-26-051542.md) | [5,344](/filings/0001628280-26-068226.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [7.7% d](/filings/0001628280-26-010705.md) | [8.7%](/filings/0001628280-26-029530.md) | [7.1%](/filings/0001628280-26-051542.md) | [(0.6%)](/filings/0001628280-26-068226.md) | [6.1% d](/filings/0001628280-26-010705.md) | [7.2%](/filings/0001628280-26-029530.md) | [7.3%](/filings/0001628280-26-051542.md) | [6.7%](/filings/0001628280-26-068226.md) |
| Diluted EPS | $ per share | not reported | [4.24](/filings/0001628280-26-029530.md) | [3.40](/filings/0001628280-26-051542.md) | [(0.37)](/filings/0001628280-26-068226.md) | not reported | [4.43](/filings/0001628280-26-029530.md) | [4.74](/filings/0001628280-26-051542.md) | [4.52](/filings/0001628280-26-068226.md) |
| Free cash flow | $m | [(344) d](/filings/0001628280-26-010705.md) | [220](/filings/0001628280-26-029530.md) | [56.3 d](/filings/0001628280-26-051542.md) | [(1,872) d](/filings/0001628280-26-068226.md) | [613 d](/filings/0001628280-26-010705.md) | [125](/filings/0001628280-26-029530.md) | [203 d](/filings/0001628280-26-051542.md) | [67.5 d](/filings/0001628280-26-068226.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [7.7](/filings/0001397911-24-000011.md) | [8.6](/filings/0001397911-25-000018.md) | [10.1](/filings/0001628280-26-010705.md) | [12.4](/filings/0001628280-26-010705.md) | [17.0](/filings/0001628280-26-010705.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [6.0%](/filings/0001397911-24-000011.md) | [9.8%](/filings/0001397911-25-000018.md) | [10.6%](/filings/0001628280-26-010705.md) | [8.5%](/filings/0001628280-26-010705.md) | [5.1%](/filings/0001628280-26-010705.md) |
| Diluted EPS | $ per share | [5.63](/filings/0001397911-24-000011.md) | [10.40](/filings/0001397911-25-000018.md) | [13.69](/filings/0001628280-26-010705.md) | [14.03](/filings/0001628280-26-010705.md) | [10.92](/filings/0001628280-26-010705.md) |
| Free cash flow | $bn | [0.2](/filings/0001397911-24-000011.md) | [1.6](/filings/0001397911-25-000018.md) | [0.1](/filings/0001628280-26-010705.md) | [(0.3)](/filings/0001628280-26-010705.md) | [(1.0)](/filings/0001628280-26-010705.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lpla/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.33bn | 4,732,991 |  | Reduced −241,264 |
| [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $1.29bn | 4,578,679 |  | Added +432,132 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $1.20bn | 4,250,828 |  | Added +119,330 |
| [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $1.18bn | 4,198,356 |  | Not compared |
| [JANUS HENDERSON GROUP PLC](/funds/1274173.md) | 2026-03-31 | $1.10bn | 3,666,780 |  | Not compared |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.08bn | 3,832,005 |  | Reduced −19,973 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.02bn | 3,613,624 |  | Added +16,656 |
| [PRINCIPAL FINANCIAL GROUP INC](/funds/1126328.md) | 2026-06-30 | $756.3m | 2,684,964 |  | Added +48,420 |
| [SAMLYN CAPITAL, LLC](/funds/1421097.md) | 2026-06-30 | $677.6m | 2,405,639 |  | Added +82,279 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $660.1m | 2,343,266 |  | Added +30,820 |

## Recent filings

[All 1,717 filings](/companies/lpla/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:08 ET | [10-Q](/filings/0001628280-26-068226.md) | Quarterly report, period 2026-09-30 | 0001628280-26-068226 |
| 2026-10-27 | 16:16 ET | [8-K](/filings/0001628280-26-067590.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-067590 |
| 2026-08-03 | 08:10 ET | [10-Q](/filings/0001628280-26-051542.md) | Quarterly report, period 2026-06-30 | 0001628280-26-051542 |
| 2026-07-30 | 16:07 ET | [8-K](/filings/0001628280-26-051046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051046 |
| 2026-05-15 | 16:11 ET | [8-K](/filings/0001628280-26-035566.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-035566 |
| 2026-05-04 | 08:38 ET | [10-Q](/filings/0001628280-26-029530.md) | Quarterly report, period 2026-03-31 | 0001628280-26-029530 |
| 2026-04-30 | 16:10 ET | [8-K](/filings/0001628280-26-028890.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-028890 |
| 2026-04-02 | 16:06 ET | [DEF 14A](/filings/0001193125-26-140066.md) | Proxy statement, period 2026-05-14 | 0001193125-26-140066 |
| 2026-02-23 | 16:48 ET | [10-K](/filings/0001628280-26-010705.md) | Annual report, period 2025-12-31 | 0001628280-26-010705 |
| 2026-01-29 | 16:07 ET | [8-K](/filings/0001628280-26-004112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-004112 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-010705.md), filed Feb 23, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/7c93c3bc-c52a-4202-81fa-3240a70ca26b)

## About the filer

- CIK: 1397911
- Tickers: LPLA
- Exchange: Nasdaq
- SIC code: 6200 Security & Commodity Brokers, Dealers, Exchanges & Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:28 ET. No prices; not investment advice.